Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2911
https://www.valueinhealthjournal.com/article/S1098-3015(17)33245-X/fulltext
Title : Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33245-X&doi=10.1016/j.jval.2017.08.2911
First page : A930
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2678
Categories :
Tags :
Regions :
ViH Article Tags :